Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proteomic Analysis of Amniotic Fluid to Predict Postnatal Renal Function in Fetuses With Renal and Urinary Tract Malformations

NCT06912490 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT06912490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06912490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proteomic Analysis of Amniotic Fluid to Predict Postnatal Renal Function in Fetuses With Renal and Urinary Tract Malformations
Lead sponsor
University Hospital, Toulouse
Phase
Not applicable
Overall status
Recruiting
Start date
July 18, 2025
Completion date
December 20, 2029
Enrollment
78 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney diseases